In Preeclampsia, the Circulating Factors Capable of Altering In Vitro Endothelial Function Precede Clinical Disease

In Preeclampsia, the Circulating Factors Capable of Altering In Vitro Endothelial Function Precede Clinical Disease is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1161/01.HYP.0000153461.58298.A4
P698PubMed publication ID15630046

P50authorMaureen MacleodQ39658662
Jenny MyersQ47504187
P2093author name stringPhilip Baker
Gary Mires
P433issue2
P407language of work or nameEnglishQ1860
P921main subjectpre-eclampsiaQ61335
P304page(s)258-263
P577publication date2005-02-01
P1433published inHypertensionQ5958695
P1476titleIn Preeclampsia, the Circulating Factors Capable of Altering In Vitro Endothelial Function Precede Clinical Disease
P478volume45

Reverse relations

cites work (P2860)
Q27003730A brief overview of preeclampsia
Q33515798A gel-free quantitative proteomics analysis of factors released from hypoxic-conditioned placentae
Q55379353Antidepressant use during pregnancy and the risk of developing gestational hypertension: a retrospective cohort study.
Q83427587Association between matrix metalloproteinase (MMP)-2 polymorphisms and MMP-2 levels in hypertensive disorders of pregnancy
Q33825219Effects of maternal serum on permeability of glomerular endothelial cell membrane
Q37229246Endothelial dysfunction. An important mediator in the pathophysiology of hypertension during pre-eclampsia
Q56970549EndothelialFOSexpression and pre-eclampsia
Q35581520IL-6-induced pathophysiology during pre-eclampsia: potential therapeutic role for magnesium sulfate?
Q39675205Low maternal middle cerebral artery Doppler resistance indices can predict future development of pre-eclampsia
Q36910638Matrix metalloproteinases as drug targets in preeclampsia
Q89763980Mechanisms linking exposure to preeclampsia in utero and the risk for cardiovascular disease
Q39816316Plasma from women with preeclampsia inhibits trophoblast invasion.
Q36682012Polymorphisms of the IL27 gene in a Chinese Han population complicated with pre-eclampsia
Q56019568Pre-eclampsia
Q35143007Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease
Q47963729Preeclamptic toxemia: a disease ripe for proteomic discovery
Q36633983Pregnancy as the prodrome to vascular dysfunction and cardiovascular risk
Q37079628Recent progress toward the understanding of the pathophysiology of hypertension during preeclampsia
Q33729040Resistance artery adaptation to pregnancy counteracts the vasoconstricting influence of plasma from normal pregnant women
Q92179614Resveratrol improves endothelial cell markers impaired by plasma incubation from women who subsequently develop preeclampsia
Q33666195Study of Nitrosative Stress in 'Pregnancy Induced Hypertension'.
Q52631138The expression and function of KCNQ potassium channels in human chorionic plate arteries from women with normal pregnancies and pre-eclampsia.
Q37088970The role of immune activation in contributing to vascular dysfunction and the pathophysiology of hypertension during preeclampsia
Q38124456Vascular dysfunction in preeclampsia